Michael SinghAssociateProskauer Rose LLPWebsitewww.proskauer.comOrganization ProfileFull ProfileBlogwww.proskauer.com/pubConnectEmail+44.20.7280.2269 Professional Biography Michael Singh is an associate in the Corporate Department and a member of the Private Funds Group. Mr. Singh graduated from the University of South Wales in 2012. More Legal and Business Bylines From Michael Singh AIFMD 2.0 – Evolution Rather than Revolution - (Posted On Thursday, March 28, 2024) SFDR Annual Reporting Deadline Looms for Many - (Posted On Thursday, March 21, 2024) ELTIF 2.0 – European Commission Proposes Amendments to the ESMA Draft RTS - (Posted On Friday, March 15, 2024) Consumer Duty Implementation: Good Practice and Areas for Improvement - (Posted On Friday, March 01, 2024) Requirements for UK High Net Worth and Self-Certified Investors Changing From 31 January 2024 - (Posted On Wednesday, December 20, 2023) A Step Closer to SFDR Changes Under ESAs’ Final Report - (Posted On Monday, December 18, 2023) Corporate Sustainability Due Diligence Directive – Initial Agreement of Final Text - (Posted On Friday, December 15, 2023) ESMA Update on Funds’ Names Using ESG or Sustainability-Related Terms - (Posted On Thursday, December 14, 2023) FCA Welcomes the Launch of the Transition Plan Taskforce Disclosure Framework – The Relevance for UK Asset Managers - (Posted On Tuesday, December 05, 2023) UK Financial Promotion Rules for Cryptoassets: Longer Implementation Period for Certain Requirements - (Posted On Wednesday, September 13, 2023) Pagination Previous page ‹ Previous Page 2 Next page Next › Current Legal Analysis Five Compliance Best Practices Every Multinational Company Should Consider for … Drafting or Updating a Global Code of Conduct by: Gregory Husisian Litigation Funding Series: Introduction and History by: Jonathan Friedland , Jeremy T. Waitzman “Tokens of Appreciation:” Supreme Court Continues to Weaken Corruption Laws by: Kurt R. Erskine 2024 Spring Regulatory Agenda Released – Suggests Rulemaking Regarding N-acetyl-L-cysteine by: Food and Drug Law at Keller and Heckman CMS Releases CY 2025 Hospital Outpatient Prospective Payment and ASC Payment Systems Proposed Rule by: Deborah R. Godes , Jeffrey Davis CMS Releases CY 2025 Physician Fee Schedule Proposed Rule by: Kristen O’Brien , Jeffrey Davis Upcoming Legal Education Events Oct 9 2024 Government Contracts Annual Update 2024 Sep 6 2024 Public Company Shareholder Engagement Summit Sep 6 2024 2024 Employment Law Symposium Aug 28 2024 REACH 30/30 - 28 August 2024 Print